Open access · CC-BY
via OpenAlex
GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL
The Research of Medical Science Review · 2026
Epigenetic alterations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Caloric restriction
Senolytics
Rapamycin / mTOR inhibition
Metformin
Exercise
Telomerase activation
Human
Abstract
Background: Epigenetic “genetic” clocks derived from DNA methylation patterns had emerged as robust correlates of biological aging and risk of age-related disease. Interventions targeting canonical aging pathways—mTOR(definition) signaling, cellular senescence(definition), mitochondrial/nicotinamide adenine dinucleotide (NAD⁺) metabolism, insulin/IGF and AMPK signaling, and lifestyle-mediated metabolic conditioning—were hypothesized to decelerate these clocks and improve multidimensional health. Objective: To test the effectiveness of targeted therapies on delaying biological aging by manipulating genetic pathways related to aging. Specifically, we evaluated whether interventions modulating mTOR, senescence, NAD⁺ metabolism, and insulin/AMPK signaling—alongside an intensive lifestyle program—could reduce DNA-methylation–based epigenetic age versus placebo over 12 months in middle-aged and older adults. Methods: We conducted a single-center, randomized, parallel-group, assessor-blinded clinical trial at a public sector tertiary care teaching hospital in Pakistan. Six arms (n=80 each) included: (1) mTOR inhibitor (low-dose rapamycin(definition)), (2) metformin, (3) senolytic (intermittent dasatinib + quercetin), (4) NAD⁺ booster (nicotinamide riboside), (5) lifestyle (calorie restriction with structured exercise), and (6) placebo/standard advice. The primary endpoint was 12-month change in DNA-methylation epigenetic age (Horvath-style composite) adjusted for leukocyte composition. Secondary endpoints included inflammatory markers (hs-CRP), cardiorespiratory fitness (VO₂max), metabolic indices, functional capacity, and safety. Results: Across 480 participants (mean baseline age 58 years; 48% women), all active arms showed mean epigenetic age deceleration versus placebo, with the largest effects in the Lifestyle and mTOR-inhibitor groups. The Lifestyle arm achieved the greatest mean reduction (−2.7 years), followed by mTOR inhibition (−2.1 years), senolytic therapy (−1.8 years), metformin (−1.4 years), and NAD⁺ booster (−0.9 years), versus a slight increase with placebo (~+0.2 years). hs-CRP fell across active arms, particularly in Lifestyle and Metformin groups, and VO₂max rose most with Lifestyle. Adverse events were acceptable and consistent with prior literature for each modality. Conclusions: In this randomized trial, manipulating conserved aging pathways significantly decelerated DNA-methylation epigenetic clocks over 12 months, with the most robust response to an intensive lifestyle program and mTOR modulation. These data support the feasibility of pathway-targeted strategies to delay biological aging in a South Asian tertiary-care setting.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5281/zenodo.18677998
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Shafiq, D.M.A.S.B.S.S.M.Z.S.A.I.I.N.U.A.H. (2026). GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL. <em>The Research of Medical Science Review</em>. https://doi.org/10.5281/zenodo.18677998
Vancouver
Shafiq DMASBSSMZSAIINUAH. GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL. The Research of Medical Science Review. 2026. doi:10.5281/zenodo.18677998.
BibTeX
@article{dr2026GENETI,
title = {GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL},
author = {Dr. Mohammad Asad Shaheen Baloch, Sidra Siddique, Maria Zainab, Summat Abbas, Irfan Ishaque, Noor Ul Ain, Hammad Shafiq},
journal = {The Research of Medical Science Review},
year = {2026},
doi = {10.5281/zenodo.18677998},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Research of Medical Science Review 2026
Open access · CC-BY
GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL
Nature Aging 2025
Open access · CC-BY
Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial
Journal of Internal Medicine 2022
Open access · CC-BY
BMI is positively associated with accelerated epigenetic aging in twin pairs discordant for body mass index
Clinical Epigenetics 2024
Open access · CC-BY
Effects of walking on epigenetic age acceleration: a Mendelian randomization study
International journal of research and scientific innovation 2026
Citation only
Chronological Versus Biological Age: The Role of Diet and Healthy Lifestyle in Modulating Epigenetic Aging
GeroScience 2026
Open access · CC-BY